How to Finance a Telehealth Platform Acquisition

Telehealth deals rarely qualify for SBA funding. Here are the capital structures that actually close in healthcare SaaS acquisitions under $5M revenue.

Find Telehealth Platform Deals SBA Calculator →

Acquiring a telehealth platform requires financing structures built around recurring ARR, HIPAA compliance risk, and reimbursement volatility. Because most telehealth businesses are SBA-ineligible due to passive income or healthcare regulatory complexity, buyers must assemble creative capital stacks using private credit, equity, and seller financing. Understanding how lenders assess payer contract stability, churn, and technology IP ownership is essential before approaching any capital source in this sector.

Financing Options for Telehealth Platform Acquisitions

Private Credit / Non-Bank Term Loans

$500K–$3M, typically up to 3x ARR for platforms with 70%+ gross margins and multi-year payer contracts10%–15% fixed or floating, depending on ARR quality, customer concentration, and reimbursement model stability

Specialty lenders and healthcare-focused private credit funds provide senior secured debt based on ARR multiples rather than hard assets, making them well-suited for telehealth SaaS acquisitions with proven subscription revenue and payer contracts.

Pros

Underwriting focused on recurring revenue and payer contract strength rather than physical collateral
Faster close timelines than bank debt, typically 30–45 days once diligence is complete
Flexible structures that can accommodate earnouts and seller equity rollovers common in telehealth deals

Cons

×Higher interest rates than conventional bank debt increase monthly debt service and compress buyer returns
×Lenders may require HIPAA security audits and BAA documentation as conditions precedent to funding
×Revenue concentration above 40% in a single health system or employer can trigger covenant restrictions or reduce advance rates

Seller Financing

15%–35% of purchase price, typically $200K–$1.2M on deals in the $1M–$5M revenue range6%–9% fixed, with principal deferred or interest-only during a 12-month transition period in most founder exits

Telehealth founders defer a portion of purchase proceeds as a promissory note, often structured to align with reimbursement policy continuity or ARR retention milestones over 12–24 months post-close.

Pros

Bridges valuation gaps between buyer and seller on platforms with uncertain post-pandemic reimbursement trajectories
Keeps the selling founder financially incentivized to support provider network and payer contract transitions
Reduces upfront equity requirement, improving buyer IRR if the platform performs as underwritten

Cons

×Seller default risk increases if reimbursement rollbacks materially reduce platform revenue post-close
×Negotiating note terms alongside earnouts can create conflicting incentive structures that complicate operations
×Founders who are burned out may become unresponsive note holders if transition responsibilities feel burdensome

Equity from Strategic or PE Investors

$1M–$5M equity checks from PE-backed roll-ups or strategic health system acquirers targeting specialty telehealth platformsNo interest rate; investors target 3x–5x return over a 4–6 year hold with preferred return provisions in most structures

Digital health roll-up platforms, regional health systems, and PE firms co-invest equity alongside an operating partner, providing capital while also contributing payer relationships, credentialing infrastructure, or EHR integration capabilities.

Pros

Strategic co-investors bring payer network access and compliance infrastructure that accelerates post-acquisition growth
Eliminates debt service burden, preserving cash flow for technology investment and provider network expansion
PE-backed platforms offer built-in exit optionality through portfolio roll-up or secondary recapitalization events

Cons

×Founders and operating buyers surrender governance control, often requiring board approval for clinical or technology decisions
×Equity raises require extensive due diligence on HIPAA posture, IP ownership, and reimbursement model sustainability
×Dilution can be significant if the platform needs follow-on capital after regulatory or reimbursement disruptions

Sample Capital Stack

$3.5M acquisition of a telehealth platform with $1.8M ARR, 72% gross margins, and multi-year employer and Medicare Advantage contracts

Purchase Price

Approximately $19,500/month combining term loan principal and interest plus seller note interest-only payments during year one

Monthly Service

Estimated 1.45x DSCR based on $340K annual platform EBITDA after operator salary adjustment, meeting most private credit minimum thresholds of 1.25x

DSCR

Private credit term loan: $1.75M (50%) | Equity from buyer and co-investor: $1.05M (30%) | Seller financing note at 7%: $700K (20%)

Model your own deal structure →

Lender Tips for Telehealth Platform Acquisitions

1Prepare a reimbursement sustainability memo showing payer mix diversity across commercial, Medicare Advantage, and direct-to-employer contracts before approaching any lender on a telehealth deal.
2Commission a third-party HIPAA security risk assessment before lender diligence begins; unresolved findings can trigger deal retrading or kill financing commitments entirely.
3Document IP ownership for all source code with signed IP assignment agreements from every developer, especially offshore contractors, to satisfy lender technology collateral requirements.
4Model two reimbursement stress scenarios — a 15% and 30% rate reduction — and show lenders how platform EBITDA and DSCR hold up to demonstrate downside resilience in your capital request.

Frequently Asked Questions

Why are most telehealth platforms ineligible for SBA 7(a) loans?

SBA lenders typically decline telehealth platforms due to passive or royalty-like recurring revenue structures, healthcare regulatory complexity, and limited hard asset collateral. Private credit or PE equity is usually the more viable path.

How do lenders evaluate reimbursement risk when financing a telehealth acquisition?

Lenders stress-test revenue by examining payer contract terms, reimbursement rate lock provisions, and reliance on expired COVID-era flexibilities. Platforms with diversified payer mixes and multi-year contracts receive significantly better advance rates.

Can earnouts be layered on top of seller financing in a telehealth deal?

Yes, but structure them carefully. Earnouts tied to ARR growth and seller notes tied to platform retention create overlapping seller obligations. Clearly separate triggers and payment waterfalls to avoid disputes during the transition period.

What is a reasonable seller financing percentage for a $2M–$4M telehealth platform acquisition?

Most telehealth deals in this range include 15%–25% seller notes. Higher seller carry is warranted when reimbursement policy uncertainty exists, customer concentration is elevated, or the founder holds key payer or provider relationships.

More Telehealth Platform Guides

Buy a Telehealth Platform Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Telehealth Platform acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required